182 related articles for article (PubMed ID: 27789026)
1. Differentiating recurrent tumours from post-treatment changes in head and neck cancers: does diffusion-weighted MRI solve the eternal dilemma?
Vaid S; Chandorkar A; Atre A; Shah D; Vaid N
Clin Radiol; 2017 Jan; 72(1):74-83. PubMed ID: 27789026
[TBL] [Abstract][Full Text] [Related]
2. Value of diffusion MR imaging in differentiation of recurrent head and neck malignancies from post treatment changes.
Jajodia A; Aggarwal D; Chaturvedi AK; Rao A; Mahawar V; Gairola M; Agarwal M; Goyal S; Koyyala VPB; Pasricha S; Tripathi R
Oral Oncol; 2019 Sep; 96():89-96. PubMed ID: 31422219
[TBL] [Abstract][Full Text] [Related]
3. Differentiation of recurrent tumor and posttreatment changes in head and neck squamous cell carcinoma: application of high b-value diffusion-weighted imaging.
Hwang I; Choi SH; Kim YJ; Kim KG; Lee AL; Yun TJ; Kim JH; Sohn CH
AJNR Am J Neuroradiol; 2013 Dec; 34(12):2343-8. PubMed ID: 23811978
[TBL] [Abstract][Full Text] [Related]
4. Feasibility study of reduced field of view diffusion-weighted magnetic resonance imaging in head and neck tumors.
Vidiri A; Minosse S; Piludu F; Curione D; Pichi B; Spriano G; Marzi S
Acta Radiol; 2017 Mar; 58(3):292-300. PubMed ID: 27287402
[TBL] [Abstract][Full Text] [Related]
5. MRI with DWI for the Detection of Posttreatment Head and Neck Squamous Cell Carcinoma: Why Morphologic MRI Criteria Matter.
Ailianou A; Mundada P; De Perrot T; Pusztaszieri M; Poletti PA; Becker M
AJNR Am J Neuroradiol; 2018 Apr; 39(4):748-755. PubMed ID: 29449279
[TBL] [Abstract][Full Text] [Related]
6. Role of diffusion-weighted echo-planar MR imaging in differentiation of residual or recurrent head and neck tumors and posttreatment changes.
Abdel Razek AA; Kandeel AY; Soliman N; El-shenshawy HM; Kamel Y; Nada N; Denewar A
AJNR Am J Neuroradiol; 2007; 28(6):1146-52. PubMed ID: 17569975
[TBL] [Abstract][Full Text] [Related]
7. Differentiation of Benign and Malignant Head and Neck Lesions With Diffusion Tensor Imaging and DWI.
Koontz NA; Wiggins RH
AJR Am J Roentgenol; 2017 May; 208(5):1110-1115. PubMed ID: 28245145
[TBL] [Abstract][Full Text] [Related]
8. Dynamic Susceptibility Contrast Perfusion-Weighted Magnetic Resonance Imaging and Diffusion-Weighted Magnetic Resonance Imaging in Differentiating Recurrent Head and Neck Cancer From Postradiation Changes.
Abdel Razek AA; Gaballa G; Ashamalla G; Alashry MS; Nada N
J Comput Assist Tomogr; 2015; 39(6):849-54. PubMed ID: 26359584
[TBL] [Abstract][Full Text] [Related]
9. Utility of MRI with morphologic and diffusion weighted imaging in the detection of post-treatment nodal disease in head and neck squamous cell carcinoma.
Mundada P; Varoquaux AD; Lenoir V; de Vito C; Dulguerov N; Ailianou A; Caparrotti F; Becker M
Eur J Radiol; 2018 Apr; 101():162-169. PubMed ID: 29571791
[TBL] [Abstract][Full Text] [Related]
10. Utility of pretreatment mean apparent diffusion coefficient and apparent diffusion coefficient histograms in prediction of outcome to chemoradiation in head and neck squamous cell carcinoma.
Srinivasan A; Chenevert TL; Dwamena BA; Eisbruch A; Watcharotone K; Myles JD; Mukherji SK
J Comput Assist Tomogr; 2012; 36(1):131-7. PubMed ID: 22261783
[TBL] [Abstract][Full Text] [Related]
11. Arterial spin labelling and diffusion-weighted magnetic resonance imaging in differentiation of recurrent head and neck cancer from post-radiation changes.
Abdel Razek AAK
J Laryngol Otol; 2018 Oct; 132(10):923-928. PubMed ID: 30387410
[TBL] [Abstract][Full Text] [Related]
12. Comparison of accuracy of intravoxel incoherent motion and apparent diffusion coefficient techniques for predicting malignancy of head and neck tumors using half-Fourier single-shot turbo spin-echo diffusion-weighted imaging.
Sakamoto J; Imaizumi A; Sasaki Y; Kamio T; Wakoh M; Otonari-Yamamoto M; Sano T
Magn Reson Imaging; 2014 Sep; 32(7):860-6. PubMed ID: 24832359
[TBL] [Abstract][Full Text] [Related]
13. Role of diffusion-weighted magnetic resonance imaging in differentiation between the viable and necrotic parts of head and neck tumors.
Razek AA; Megahed AS; Denewer A; Motamed A; Tawfik A; Nada N
Acta Radiol; 2008 Apr; 49(3):364-70. PubMed ID: 18365828
[TBL] [Abstract][Full Text] [Related]
14. Tissue characterization of head and neck lesions using diffusion-weighted MR imaging with SPLICE.
Sakamoto J; Yoshino N; Okochi K; Imaizumi A; Tetsumura A; Kurohara K; Kurabayashi T
Eur J Radiol; 2009 Feb; 69(2):260-8. PubMed ID: 18023549
[TBL] [Abstract][Full Text] [Related]
15. ADC for Differentiation between Posttreatment Changes and Recurrence in Head and Neck Cancer: A Systematic Review and Meta-analysis.
Baba A; Kurokawa R; Kurokawa M; Hassan O; Ota Y; Srinivasan A
AJNR Am J Neuroradiol; 2022 Mar; 43(3):442-447. PubMed ID: 35210272
[TBL] [Abstract][Full Text] [Related]
16. Diffusion-weighted imaging for head and neck squamous cell carcinoma: quantifying repeatability to understand early treatment-induced change.
Hoang JK; Choudhury KR; Chang J; Craciunescu OI; Yoo DS; Brizel DM
AJR Am J Roentgenol; 2014 Nov; 203(5):1104-8. PubMed ID: 25341151
[TBL] [Abstract][Full Text] [Related]
17. Differentiation of benign and malignant lesions of the tongue by using diffusion-weighted MRI at 3.0 T.
Li S; Cheng J; Zhang Y; Zhang Z
Dentomaxillofac Radiol; 2015; 44(7):20140325. PubMed ID: 25823772
[TBL] [Abstract][Full Text] [Related]
18. Diffusion-weighted magnetic resonance imaging early after chemoradiotherapy to monitor treatment response in head-and-neck squamous cell carcinoma.
Vandecaveye V; Dirix P; De Keyzer F; Op de Beeck K; Vander Poorten V; Hauben E; Lambrecht M; Nuyts S; Hermans R
Int J Radiat Oncol Biol Phys; 2012 Mar; 82(3):1098-107. PubMed ID: 21514067
[TBL] [Abstract][Full Text] [Related]
19. Time-dependent diffusion MRI to distinguish malignant from benign head and neck tumors.
Iima M; Yamamoto A; Kataoka M; Yamada Y; Omori K; Feiweier T; Togashi K
J Magn Reson Imaging; 2019 Jul; 50(1):88-95. PubMed ID: 30578563
[TBL] [Abstract][Full Text] [Related]
20. Pretreatment ADC is not a prognostic factor for local recurrences in head and neck squamous cell carcinoma when clinical T-stage is known.
Peltenburg B; Driessen JP; Vasmel JE; Pameijer FA; Janssen LM; Terhaard CHJ; de Bree R; Philippens MEP
Eur Radiol; 2020 Feb; 30(2):1228-1231. PubMed ID: 31529258
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
